Ep 82 | Recap of 340B Developments from 2025
In this episode, Greg and Rob recap key developments in the 340B space from 2025. They’ll discuss the flurry of activity in recent months related to 340B rebates, project the impact of the OBBB on DS...
22 Dec 202545min
Ep 80 | 340B Updates, including CMS CY26 OPPS Final Rule and Rebate Developments
In this episode, Greg and Rob catch up on some clarifications gained around the upcoming 340B rebate model, including purchasing requirements and developments with select chain retail pharmacies updat...
1 Dec 202547min
Ep 79 | 340B Rebate Model Update
In this episode, Greg and Rob share initial reactions to the HRSA update on 340B rebate model implementation. They’ll review the communication provided by HRSA on October 30th on their website, as wel...
3 Nov 202552min
Ep 78 | Government Shutdown, Most Favored Nations Pricing and Direct-to-Consumer Pharmacy Supply Chain Discussion
In this episode, Greg and Rob chat about what the government shutdown might mean for 340B Program oversight in the short-term. They’ll also discuss a flurry of developments from manufacturers recently...
13 Okt 202533min
Ep 77 | DSH Hospital Threats
In this episode, Greg and Rob are joined by SpendMend colleague Heather Lynch, to talk about how H.R.1 (i.e. One Big Beautiful Bill Act, or OBBBA) could impact 340B covered entities in the long run. T...
29 Sep 202550min
Ep 76 | HRSA DRL Updates & 340B Rebate Comments
In this episode, Greg and Rob review recent changes made to the HRSA Audit Data Request List (DRL). They also discuss some of the comments provided by the public to HRSA regarding potential 340B rebat...
15 Sep 20251h 1min
Ep 75 | 340B Rebate Guidance Update – HRSA FAQs
In this episode, Greg and Rob catch up on insights gathered and lessons learned from various forums our team has attended over the last few weeks. Also, they discuss the recently posted FAQ page provi...
1 Sep 202550min
